COMMUNIQUÉ DE PRESSE publié le 14/08/2023 à 14:00, il y a 1 année 3 mois Jaguar Health Reports Second Quarter 2023 Financial Results
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 14:30, il y a 1 année 3 mois Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
COMMUNIQUÉ DE PRESSE publié le 09/08/2023 à 14:30, il y a 1 année 3 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 08/08/2023 à 14:30, il y a 1 année 3 mois Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
COMMUNIQUÉ DE PRESSE publié le 07/08/2023 à 14:30, il y a 1 année 3 mois Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
COMMUNIQUÉ DE PRESSE publié le 03/08/2023 à 14:30, il y a 1 année 3 mois Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
COMMUNIQUÉ DE PRESSE publié le 02/08/2023 à 14:30, il y a 1 année 3 mois REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
COMMUNIQUÉ DE PRESSE publié le 01/08/2023 à 14:40, il y a 1 année 3 mois Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
COMMUNIQUÉ DE PRESSE publié le 27/07/2023 à 14:30, il y a 1 année 3 mois In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon
COMMUNIQUÉ DE PRESSE publié le 26/07/2023 à 14:30, il y a 1 année 3 mois Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Publié le 22/11/2024 à 16:15, il y a 54 minutes NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 21/11/2024 à 06:58, il y a 1 jour 10 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 1 jour 10 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 22/11/2024 à 16:00, il y a 1 heure 9 minutes Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Publié le 22/11/2024 à 15:55, il y a 1 heure 14 minutes Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Publié le 22/11/2024 à 15:15, il y a 1 heure 54 minutes Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Publié le 22/11/2024 à 14:45, il y a 2 heures 24 minutes Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Publié le 22/11/2024 à 14:30, il y a 2 heures 39 minutes Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best
Publié le 22/11/2024 à 16:00, il y a 1 heure 9 minutes AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Publié le 22/11/2024 à 15:27, il y a 1 heure 42 minutes EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Publié le 22/11/2024 à 14:46, il y a 2 heures 22 minutes Form 8.3 - The Vanguard Group, Inc.: International Paper Company
